Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E25.19 EPS (ttm)2.47 Insider Own1.50% Shs Outstand46.68M Perf Week10.08%
Market Cap2.90B Forward P/E17.43 EPS next Y3.57 Insider Trans1.30% Shs Float45.79M Perf Month2.84%
Income118.60M PEG2.52 EPS next Q0.80 Inst Own96.00% Short Float4.49% Perf Quarter15.95%
Sales1.22B P/S2.38 EPS this Y2.40% Inst Trans0.05% Short Ratio4.79 Perf Half Y8.58%
Book/sh14.31 P/B4.35 EPS next Y7.40% ROA6.90% Target Price61.73 Perf Year30.16%
Cash/sh2.76 P/C22.54 EPS next 5Y9.98% ROE17.60% 52W Range47.33 - 62.50 Perf YTD17.33%
Dividend- P/FCF17.04 EPS past 5Y17.90% ROI9.10% 52W High-0.43% Beta0.91
Dividend %- Quick Ratio1.80 Sales past 5Y-2.10% Gross Margin34.90% 52W Low31.48% ATR1.63
Employees7700 Current Ratio2.20 Sales Q/Q16.50% Oper. Margin13.70% RSI (14)60.57 Volatility3.90% 2.75%
OptionableYes Debt/Eq1.21 EPS Q/Q29.30% Profit Margin9.60% Rel Volume1.00 Prev Close60.43
ShortableYes LT Debt/Eq1.16 EarningsOct 29 AMC Payout0.00% Avg Volume428.70K Price62.23
Recom2.70 SMA204.82% SMA504.37% SMA2009.22% Volume428,253 Change2.98%
13-Feb-14Reiterated Barclays Equal Weight $41 → $55
21-Nov-13Initiated Deutsche Bank Hold $55
17-Sep-13Initiated UBS Neutral $49
03-Jun-13Reiterated Barclays Equal Weight $38 → $41
02-May-13Reiterated ISI Group Neutral $45.50 → $44.50
14-Feb-13Reiterated ISI Group Neutral $40.50 → $43
14-Jul-11Initiated BB&T Capital Mkts Buy $47
05-May-11Reiterated UBS Neutral $40 → $42
06-Jan-11Downgrade Deutsche Bank Buy → Hold $37 → $37
12-May-10Upgrade Robert W. Baird Neutral → Outperform $37
07-Jan-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
09-Nov-09Downgrade Barclays Capital Overweight → Equal Weight
13-May-09Initiated Deutsche Securities Hold
20-Apr-09Downgrade Jefferies & Co Buy → Hold $33
11-Feb-09Reiterated Jefferies & Co Buy $31 → $33
05-Feb-09Reiterated Barclays Capital Overweight $42 → $38
30-Jan-09Downgrade UBS Neutral → Sell
26-Jan-09Reiterated Jefferies & Co Buy $35 → $31
20-Jan-09Reiterated Barclays Capital Overweight $44 → $42
20-Nov-08Reiterated UBS Neutral $30 → $22
08-Oct-14 04:15PM  Charles River Laboratories Schedules Third-Quarter 2014 Earnings Release and Conference Call Business Wire
09-Sep-14 09:08AM  Charles River (CRL) Stock: Moving Average Crossover Alert Zacks
08-Sep-14 08:00AM  Charles River Laboratories to Present at Morgan Stanley Global Healthcare Conference Business Wire
04-Sep-14 06:53AM  Why Intrexon (XON) Could Be Positioned for a Slump Zacks
27-Aug-14 06:55AM  iKang Healthcare Slumps: KANG Plunges 13.6% in Session Zacks
26-Aug-14 07:06AM  iKang Healthcare Group, Inc. (KANG) Jumps: Stock Surges 10.1% Zacks
18-Aug-14 06:54AM  Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again Zacks
15-Aug-14 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials EDGAR Online Financials
13-Aug-14 06:00AM  Jim Cramer's Top Stock Picks: TSLA TNET CRL at TheStreet
12-Aug-14 08:13PM  Jim Cramer's 'Mad Money' Recap: Stocks That Stand the Test of Time at TheStreet
06:50PM  Cramer: Is Charles River getting ready to run? at CNBC
08-Aug-14 07:30AM  Charles River Laboratories (CRL) Jumps: Stock Moves 5% Higher Zacks
07-Aug-14 01:10PM  Charles River Beats on Q2 Earnings & Revenues, Outlook Upped Zacks +5.04%
09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today CCBN
06:02AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
06-Aug-14 04:40PM  Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations Business Wire
07:07AM  Q2 2014 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
24-Jul-14 09:00AM  Charles River Laboratories to Webcast Investor Meeting Business Wire
22-Jul-14 04:51PM  John Rogers' Ariel Fund Second Quarter 2014 Commentary Gurufocus
07-Jul-14 04:15PM  Charles River Laboratories Schedules Second-Quarter 2014 Earnings Release and Conference Call Business Wire
05-Jun-14 10:30AM  Insider Trading Alert - FWLT, CRL And SAH Traded By Insiders at TheStreet
02-Jun-14 09:33AM  Charles River Laboratories to Present at Jefferies and William Blair Conferences Business Wire
20-May-14 09:37AM  UPDATE: Morgan Stanley Reiterates On Charles River Laboratories Following CEO Conference Call Benzinga
12-May-14 11:29AM  [video] Jim Cramer Says Yahoo Should Buy Yelp With Its Alibaba Payday at TheStreet
09-May-14 12:43PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05-May-14 04:59PM  Charles River Laboratories to Present at Bairds Growth Stock Conference Business Wire
02-May-14 08:50AM  Charles River Laboratories (CRL) is now in Oversold Territory Zacks
01-May-14 03:41PM  Charles River, PAREXEL lower after peers combine at theflyonthewall.com
02:36PM  Charles River Beats on Earnings, Guidance Upped Zacks
09:00AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
30-Apr-14 04:49PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
04:44PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:30PM  Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations Business Wire
10:50AM  Express Scripts Misses Earnings, Guides Low Zacks
07:07AM  Q1 2014 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
06:55AM  Is Charles River Laboratories (CRL) Stock a Solid Choice Right Now? Zacks
29-Apr-14 03:26PM  Charles River Laboratories: A Well-Positioned CRO Due To Blossom In Pre-Clinical Services at Seeking Alpha
07-Apr-14 04:15PM  Charles River Laboratories Schedules First-Quarter 2014 Earnings Release and Conference Call Business Wire
04-Apr-14 01:00PM  Must-know catalysts and valuation for ICON Market Realist -5.97%
11:43AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, EDGAR Online
09:00AM  Why analyst expectation of a margin compression is unreasonable Market Realist
03-Apr-14 04:22PM  Market overview for CROs suggest healthy growth for ICON Market Realist
01-Apr-14 01:35AM  Charles River Laboratories and Galapagos complete transaction GlobeNewswire
01:32AM  Charles River Laboratories and Galapagos complete transaction Thomson Reuters ONE
31-Mar-14 08:48PM  Charles River Laboratories Completes the Acquisition of the CRO Services Division of Galapagos NV Business Wire
19-Mar-14 06:00AM  Jim Cramer's Top Stock Picks: CRL TSLA EOG at TheStreet
18-Mar-14 08:07PM  Jim Cramer's 'Mad Money' Recap: Profits Still Matter at TheStreet
06:16PM  Cramer's single stock for those baffled by biotech at CNBC
06:15PM  [video] Charles River CEO: Critical to drug development process at CNBC
17-Mar-14 04:46PM  Charles River Laboratories International Larger Than S&P 500 Component Cliffs Natural Resources at TheStreet
14-Mar-14 06:30PM  Best States, Worst States For Dividend Lovers at Forbes
04:40PM  Charles River Acquires CRO Division of Galapagos Zacks
13-Mar-14 11:39AM  Charles River Aims To Be 'One-Stop Shop' With Buyout Optionetics
09:00AM  Charles River Laboratories to Acquire the CRO Services Division of Galapagos NV Call scheduled for 9:00 am ET today CCBN
05:00AM  Galapagos NV BioFocus Service Operations Acquired by Charles River Laboratories Call scheduled for 5:00 am ET today CCBN
03:18AM  Charles River to buy Galapagos drug service operations Reuters
02:47AM  Charles River Laboratories to acquire Galapagos' Argenta and BioFocus service operations for up to 134 million Thomson Reuters ONE
02:45AM  Charles River Laboratories to Acquire the CRO Services Division of Galapagos NV Business Wire
10-Mar-14 01:00PM  Insider Trading Alert - ETN, PCG And CRL Traded By Insiders Optionetics
03-Mar-14 08:30AM  Charles River Laboratories to Present at Cowen and Raymond James Conferences Business Wire
28-Feb-14 10:45AM  Insider Trading Alert - CRL, IDA And DAL Traded By Insiders at TheStreet
25-Feb-14 05:23PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report EDGAR Online
12-Feb-14 03:34PM  Charles River Laboratories' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:15AM  Charles River Beats Earnings Estimates in Q4 Zacks
08:30AM  Taylor Morrison Home Corp Earnings Call scheduled for 8:30 am ET today CCBN
06:03AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
11-Feb-14 04:30PM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2013 Results from Continuing Operations and Provides 2014 Guidance Business Wire
07:07AM  Q4 2013 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
10-Feb-14 12:19PM  The market in a minute: Sentiment reboot at MarketWatch
11:50AM  Will Zoetis (ZTS) Miss Estimates in Q4? Zacks
04-Feb-14 05:53PM  Late-stage drug research powers Covance profit beat Reuters
27-Jan-14 04:15PM  Charles River Laboratories Schedules Fourth-Quarter 2013 Earnings and 2014 Guidance Release and Conference Call Business Wire
13-Jan-14 08:00AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FOSTER JAMES CChairman, President and CEOOct 03Option Exercise47.68136,6476,515,753487,611Oct 07 02:10 PM
GELLER JORGCorporate Executive VPOct 03Sale61.6089355,00748,329Oct 06 12:44 PM
FOSTER JAMES CChairman, President and CEOOct 03Sale62.00136,6478,472,114350,964Oct 07 02:10 PM
Molho DavideCorporate Executive VPSep 04Option Exercise58.584,900287,04248,204Sep 05 11:24 AM
Molho DavideCorporate Executive VPSep 04Sale61.344,900300,57143,304Sep 05 11:24 AM
MASSARO GEORGEDirectorAug 26Option Exercise28.2910,440295,34826,950Aug 27 03:30 PM
MASSARO GEORGEDirectorAug 26Sale60.0010,440626,40016,510Aug 27 03:30 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Option Exercise47.6544,6492,127,419148,860Aug 19 03:23 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Sale59.3821,4931,276,172104,211Aug 19 03:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOAug 18Sale59.2523,1561,372,053125,704Aug 19 03:23 PM
WALLMAN RICHARD FDirectorAug 12Sale58.203,240188,56816,180Aug 13 01:17 PM
CHUBB STEPHEN DDirectorJun 02Sale52.932,000105,85524,365Jun 04 07:06 AM
Kochevar Deborah TurnerDirectorMay 22Option Exercise43.394,030174,86220,620May 23 09:41 AM
Kochevar Deborah TurnerDirectorMay 22Sale53.156,150326,88414,470May 23 09:41 AM
MASSARO GEORGEDirectorMay 09Option Exercise50.4025012,60016,760May 12 02:46 PM
MASSARO GEORGEDirectorMay 09Sale52.4625013,11416,510May 12 02:46 PM
MASSARO GEORGEDirectorMay 08Sale52.701,62085,36716,510May 09 04:55 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Option Exercise24.8015,000372,000119,211May 06 03:00 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale51.119,070463,564104,711May 06 03:07 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale51.3650025,679104,211May 06 03:08 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOMay 05Sale50.765,430275,620113,781May 06 03:00 PM
Molho DavideCorporate Executive VPMar 07Option Exercise37.9229,5001,118,64072,804Mar 11 01:04 PM
GILLETT NANCYCorporate Executive VPMar 07Sale57.351106,30938,515Mar 07 12:58 PM
Molho DavideCorporate Executive VPMar 07Sale57.311,70097,43343,304Mar 11 01:07 PM
Molho DavideCorporate Executive VPMar 07Sale57.2527,8001,591,44345,004Mar 11 01:04 PM
GILLETT NANCYCorporate Executive VPMar 06Sale58.3710,000583,66338,625Mar 07 12:58 PM
GILLETT NANCYCorporate Executive VPMar 04Option Exercise37.5013,650511,87962,275Mar 06 01:46 PM
GILLETT NANCYCorporate Executive VPMar 04Sale58.9813,650805,03448,625Mar 06 01:46 PM
CHUBB STEPHEN DDirectorMar 03Sale58.702,000117,40023,645Mar 05 10:29 AM
GILLETT NANCYCorporate Executive VPFeb 28Option Exercise38.3211,040423,03354,202Mar 04 04:00 PM
GELLER JORGCorporate Executive VPFeb 28Option Exercise37.8919,515739,43768,737Mar 03 06:09 PM
GELLER JORGCorporate Executive VPFeb 28Sale60.036,500390,16349,222Mar 03 06:14 PM
GELLER JORGCorporate Executive VPFeb 28Sale59.417,486444,74755,722Mar 03 06:12 PM
GELLER JORGCorporate Executive VPFeb 28Sale59.065,529326,52063,208Mar 03 06:09 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale60.0781348,84143,162Mar 04 04:03 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale59.615,727341,37943,975Mar 04 04:01 PM
GILLETT NANCYCorporate Executive VPFeb 28Sale59.114,500265,99849,702Mar 04 04:00 PM
GELLER JORGCorporate Executive VPFeb 27Sale59.9458234,88549,222Mar 03 09:25 AM
GILLETT NANCYCorporate Executive VPFeb 27Sale60.004,000240,00043,162Feb 28 11:32 AM
FOSTER JAMES CChairman, President and CEOFeb 26Option Exercise37.9240,0001,516,800380,258Feb 28 05:03 PM
GELLER JORGCorporate Executive VPFeb 26Sale58.7843125,33549,804Feb 28 10:11 AM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.926,702394,882340,258Feb 28 05:06 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.5610,454612,214369,804Feb 28 05:03 PM
FOSTER JAMES CChairman, President and CEOFeb 26Sale58.8422,8441,344,105347,360Feb 28 05:05 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale58.5520,2431,185,293350,298Feb 27 04:38 PM
FOSTER JAMES CChairman, President and CEOFeb 25Sale58.734,954290,951345,344Feb 27 04:39 PM
GELLER JORGCorporate Executive VPFeb 25Sale58.493,188186,46050,235Feb 27 10:13 AM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise38.2146,1671,763,937402,008Feb 26 05:03 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale59.1212,027710,999345,344Feb 26 05:07 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale58.9117,0001,001,547357,371Feb 26 05:05 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale58.7417,1401,006,872374,371Feb 26 05:03 PM
GELLER JORGCorporate Executive VPFeb 24Sale58.8876945,28053,423Feb 26 09:17 AM
GILLETT NANCYCorporate Executive VPFeb 20Sale58.964,000235,83550,510Feb 24 09:18 AM
CHUBB STEPHEN DDirectorFeb 19Option Exercise50.406,000302,40030,843Feb 21 12:26 PM
CHUBB STEPHEN DDirectorFeb 19Sale58.355,198303,27825,645Feb 21 12:26 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Option Exercise24.8015,000372,000119,539Feb 20 02:23 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:34 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:30 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.351,00058,346104,039Feb 20 02:25 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 18Sale58.0514,000812,661105,539Feb 20 02:23 PM
MILNE GEORGE M JRDirectorFeb 13Option Exercise50.406,000302,40034,070Feb 18 09:59 AM
MILNE GEORGE M JRDirectorFeb 13Sale58.556,000351,28928,070Feb 18 09:59 AM
JOHST DAVID PCorp Executive VPJan 13Option Exercise37.0319,750731,343161,549Jan 14 03:27 PM
JOHST DAVID PCorp Executive VPJan 13Sale58.0019,7501,145,500141,799Jan 14 03:27 PM
MASSARO GEORGEDirectorJan 07Option Exercise50.405,750289,80021,160Jan 09 09:12 AM
MASSARO GEORGEDirectorJan 07Sale54.005,750310,50015,410Jan 09 09:12 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Option Exercise24.808,150202,120112,689Dec 24 10:01 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Sale52.983,150166,889104,539Dec 24 10:03 AM
ACKERMAN THOMAS FCorp. Executive VP & CFODec 20Sale52.725,000263,615107,689Dec 24 10:01 AM
GELLER JORGCorporate Executive VPDec 04Option Exercise46.607,200335,52061,392Dec 06 12:10 PM
GELLER JORGCorporate Executive VPDec 04Sale51.937,200373,93054,192Dec 06 12:10 PM
CHUBB STEPHEN DDirectorDec 02Sale51.922,000103,83726,843Dec 03 11:31 AM
FOSTER JAMES CChairman, President and CEONov 22Option Exercise46.6084,5503,940,030448,930Nov 25 04:24 PM
JOHST DAVID PCorp Executive VPNov 22Option Exercise45.1649,6502,242,384191,449Nov 25 04:26 PM
JOHST DAVID PCorp Executive VPNov 22Sale52.0049,6502,581,800141,799Nov 25 04:26 PM
FOSTER JAMES CChairman, President and CEONov 22Sale52.0084,5504,396,600364,380Nov 25 04:24 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 21Option Exercise46.6031,6501,474,890136,689Nov 25 10:56 AM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 21Sale51.5331,6501,631,047105,039Nov 25 10:56 AM
Molho DavideCorporate Executive VPNov 15Option Exercise31.6519,584619,85160,476Nov 19 09:53 AM
Molho DavideCorporate Executive VPNov 15Sale51.7119,5841,012,65440,892Nov 19 09:53 AM
GILLETT NANCYCorporate Executive VPNov 13Option Exercise46.6025,3881,183,08179,898Nov 15 09:19 AM
GILLETT NANCYCorporate Executive VPNov 13Sale51.0025,3881,294,86654,510Nov 15 09:19 AM
GELLER JORGCorporate Executive VPNov 08Option Exercise49.8625,1991,256,42279,391Nov 13 09:22 AM
GELLER JORGCorporate Executive VPNov 08Sale49.9611,505574,73754,192Nov 13 09:26 AM
GELLER JORGCorporate Executive VPNov 08Sale49.7813,694681,71365,697Nov 13 09:22 AM
FOSTER JAMES CChairman, President and CEONov 04Option Exercise43.07150,0006,460,500516,580Nov 06 03:44 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 04Option Exercise43.0720,200870,014125,239Nov 06 01:35 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 04Sale50.0020,2001,010,000105,039Nov 06 01:35 PM
FOSTER JAMES CChairman, President and CEONov 04Sale50.00150,0007,500,000366,580Nov 06 03:44 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 01Option Exercise49.5315,000743,012120,039Nov 05 03:17 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 01Sale49.648,500421,950105,039Nov 05 03:18 PM
ACKERMAN THOMAS FCorp. Executive VP & CFONov 01Sale49.396,500321,062113,539Nov 05 03:17 PM